Radiation Oncology/Therapy: Page 115

Accuray sees revenue boost in Q1
By AuntMinnie.com staff writers
Radiation oncology firm Accuray said that revenue increased by 5% for its first fiscal quarter.
October 24, 2017
ViewRay touts pancreatic cancer study results
By AuntMinnie.com staff writers
Image-guided radiation therapy developer ViewRay is touting study results showing that higher radiation doses with its adaptive MR-guided radiation therapy technology may improve survival in patients with pancreatic cancer while maintaining a favorable toxicity profile.
October 24, 2017
French court denies Varian effort to block Accuray deal
By AuntMinnie.com staff writers
A French court has rejected an appeal filed by Varian Medical Systems to block the University Hospital of Tours' purchase of the TomoTherapy system from radiation oncology firm Accuray.
October 18, 2017
RSNA to publish 3 new online journals
By AuntMinnie.com staff writers
The RSNA will begin publishing three new subspecialty online journals in 2019 on cancer imaging, cardiothoracic imaging, and machine learning/artificial intelligence.
October 17, 2017
Xstrahl lands FDA nod for superficial x-ray therapy
By AuntMinnie.com staff writers
X-ray and radiation therapy technology developer Xstrahl has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Photoelectric Therapy System, an x-ray therapy system designed to treat nonmelanoma skin cancer and superficial lesions.
October 16, 2017
Elekta partners with Alliance for Cancer Care
By AuntMinnie.com staff writers
Radiation oncology vendor Elekta has inked an agreement with the Alliance for Cancer Care, a cancer care network in Washington and Idaho.
October 3, 2017
IsoRay revenues climb in Q4
By AuntMinnie.com staff writers
Growth in its number of customers helped medical isotope developer IsoRay to a 22% increase in revenue for its fiscal fourth quarter.
September 28, 2017
IsoRay highlights cesium-131 brachytherapy research
By AuntMinnie.com staff writers
Medical isotope developer IsoRay is highlighting research that suggests the isotope cesium-131 is beneficial for permanent interstitial brachytherapy in gynecologic/pelvic cancers.
September 25, 2017
Accuray touts CyberKnife clinical results
By AuntMinnie.com staff writers
Radiation oncology firm Accuray is highlighting data from a study that showed 98.4% of men with low-risk prostate cancer who underwent stereotactic body radiation therapy (SBRT) with the company's CyberKnife system had local disease control 10 years later.
September 25, 2017
ASTRO: Breast radiation 'less scary' than expected
By AuntMinnie.com staff writers
Breast cancer patients find the experience of radiation therapy to be less intimidating than they expected, according to research presented at the American Society for Radiation Oncology (ASTRO) meeting in San Diego.
September 25, 2017
Blue Earth highlights Axumin clinical results at ASTRO
By AuntMinnie.com staff writers
Molecular imaging firm Blue Earth Diagnostics is highlighting interim clinical results at the American Society for Radiation Oncology (ASTRO) meeting in San Diego from a trial involving its Axumin (fluciclovine F-18) PET radiopharmaceutical.
September 25, 2017
ASTRO: Short radiation course safe for breast cancer
By AuntMinnie.com staff writers
A shorter-course, higher-dose protocol for breast cancer radiation therapy is safe for patients younger than 50, according to research presented at the American Society for Radiation Oncology (ASTRO) annual meeting in San Diego.
September 25, 2017
2016 10 18 11 34 57 70 Check Mark 400
Previous Page
Page 115 of 464
Next Page